Capasso Planning Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Sell |
6,851
-1,006
| -13% | -$187K | 0.72% | 24 |
|
|
2025
Q1 | $1.65M | Sell |
7,857
-787
| -9% | -$165K | 0.69% | 29 |
|
|
2024
Q4 | $1.54M | Sell |
8,644
-2,598
| -23% | -$462K | 0.61% | 33 |
|
|
2024
Q3 | $2.22M | Sell |
11,242
-2,030
| -15% | -$401K | 0.66% | 29 |
|
|
2024
Q2 | $2.28M | Buy |
13,272
+9,733
| +275% | +$1.67M | 0.74% | 31 |
|
|
2024
Q1 | $645K | Buy |
3,539
+112
| +3% | +$20.4K | 0.27% | 52 |
|
|
2023
Q4 | $531K | Sell |
3,427
-2
| -0.1% | -$310 | 0.25% | 56 |
|
|
2023
Q3 | $511K | Sell |
3,429
-39
| -1% | -$5.81K | 0.27% | 49 |
|
|
2023
Q2 | $467K | Buy |
3,468
+52
| +2% | +$7.01K | 0.25% | 57 |
|
|
2023
Q1 | $544K | Buy |
3,416
+72
| +2% | +$11.5K | 0.32% | 50 |
|
|
2022
Q4 | $540K | Buy |
3,344
+115
| +4% | +$18.6K | 0.34% | 50 |
|
|
2022
Q3 | $433K | Sell |
3,229
-9
| -0.3% | -$1.21K | 0.3% | 56 |
|
|
2022
Q2 | $496K | Buy |
3,238
+71
| +2% | +$10.9K | 0.35% | 51 |
|
|
2022
Q1 | $513K | Hold |
3,167
| – | – | 0.36% | 47 |
|
|
2021
Q4 | $429K | Buy |
+3,167
| New | +$429K | 0.31% | 53 |
|